Edoxaban,a new oral anticoagulant,as a direct factor Xa inhibitor,has the advantages of rapid oral absorption,small interaction between drug and food,no routine monitoring of coagulation indicators,good tolerance,safety and compliance.Although it has been on the market late,it is more and more widely used in the clinical practice of cardiovascular disease.This article reviews the research progress of edoxaban in cardiovascular disease.
关键词
艾多沙班/非瓣膜性心房颤动/非维生素K拮抗剂口服抗凝药物/心血管疾病
Key words
Edoxaban/Non-valvular atrial fibrillation/Non-vitamin K antagonist oral anticoagulants/Cardiovascular disease
维普
万方数据